Background Poly (ADP-ribose) polymerase inhibitors (PARPi) has been increasingly
adopted for metastatic castration-resistance prostate cancer (mCRPC) patients with …

Hepatocellular carcinoma accounts for the majority proportion of primary liver cancer and it
is the fourth leading cause of cancer-related mortality in the world, while multifactorial drug …

The recent millennium has witnessed a notable shift in consumer focus towards natural
products for addressing lifestyle-related disorders, driven by their safety and cost …

Background The Gleason grading system is a major tool used for prediction of prostate
cancer (PCa) behavior. Because of heterogeneity and sampling errors, prognosis is variable …

Oligometastatic prostate cancer (OMPC) encompasses a heterogenous group of clinical
entities defined by the timing of the development of metastases. These include de novo …

Prostate cancer (PCa) is the second most common cancer in males worldwide. Androgen
deprivation therapy (ADT) is the primary treatment method used for PCa. Although more …

Simple Summary Uterine or endometrial cancer is one of the most common types of cancer
among the female population. Different alterations of molecules are related to many types of …

Beta-Parvin (PARVB) is an actin-binding protein with functionality in extracellular matrix
binding. Recent studies suggest its potential as a biomarker for various cancers, given its …

Molecular imaging is a key tool in the diagnosis and treatment of prostate cancer (PCa).
Magnetic Resonance (MR) plays a major role in this respect with nuclear medicine imaging …

PARP inhibitors have changed the management of advanced high-grade epithelial ovarian
cancer (EOC), especially homologous recombinant (HR)-deficient advanced high-grade …